Rate this post

MedVi vs BMI MD: Compare GLP-1 Programs & Pricing

Side-by-side MedVi and BMI MD: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

MedVi and BMI MD are two established telehealth providers offering GLP-1–based weight management programs. This article compares MedVi vs BMI MD to help you identify which best fits your goals and preferences.

Visit MedVi
Explore BMI MD

MedVi vs BMI MD: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
MedVi	$179.00	$279.00	$120 off first month (Code: )	— No
BMI MD				—

MedVi vs BMI MD: Medical Process & Accessibility

MedVi focuses on a rapid telehealth intake, electronic medical record review, and clinician approval within 24‑48 hours. After approval, a licensed U.S. pharmacy compounds and ships the GLP‑1 medication directly to the patient’s door. BMI MD uses a slightly longer onboarding process that includes a detailed health questionnaire, optional video consult, and a scheduled follow‑up to fine‑tune dosing. Both platforms operate entirely online, comply with FDA regulations for compounded medications, and require a valid prescription from a U.S.-licensed prescriber.

Start with MedVi

MedVi vs BMI MD: Pricing Comparison

MedVi offers semaglutide starting at $179.00 per month and tirzepatide at $279.00 per month. Because BMI MD does not publicly list starting prices on its site, a direct price comparison is not possible at this time. The lower price for each medication—where data is available—is highlighted in bold. MedVi also provides a one‑time $120 discount on the first month’s supply. No membership fees are required to begin treatment.

When budgeting for GLP‑1 therapy, consider additional costs such as lab work (often covered by insurance), telehealth visit fees (typically $0‑$50), and shipping. Both providers accept most major credit cards and may offer financing options for eligible patients.

Compare BMI MD Pricing

MedVi vs BMI MD: Clinical Oversight & Support

Both companies assign a board‑certified endocrinologist or weight‑management specialist to review each prescription. MedVi emphasizes a streamlined approval workflow, making it ideal for patients who want to start treatment quickly. BMI MD places a stronger emphasis on ongoing clinical monitoring, with scheduled virtual check‑ins every 4‑6 weeks to assess response, side effects, and dose adjustments.

Book a Consultation with MedVi

MedVi vs BMI MD: Medication Quality & Safety

Both providers dispense compounded GLP‑1 medications from FDA‑registered, USP‑verified pharmacies in the United States. While these products are not the brand‑name injections (e.g., Wegovy® or Mounjaro®), they contain the same active ingredients in clinically appropriate concentrations. Each prescription is reviewed by a licensed clinician, and the pharmacy follows Good Manufacturing Practices (GMP) to ensure sterility and potency.

MedVi vs BMI MD: Customer Experience

Patient testimonials for MedVi frequently cite affordability, fast shipping, and a straightforward online portal as standout features. Users of BMI MD often highlight the thoroughness of the clinical team, personalized diet and lifestyle guidance, and a sense of ongoing partnership throughout the weight‑loss journey.

Explore BMI MD Reviews

MedVi vs BMI MD: Final Verdict

Choose MedVi if you prioritize lower out‑of‑pocket cost, a quick start, and a simple, no‑membership model. Opt for BMI MD if you desire more intensive clinical follow‑up, a structured support program, and are willing to investigate pricing directly with the provider.

Join MedVi
Get Started with BMI MD

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice